Women's Fem Dophilus

GR-1/RC-14 and Vaginal Flore (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement. Martinez, et al. Can J Microbiol 2009;55:133-138 Box contains smaller, Activ-Vial moisture-controlled desiccant bottle for better stability of probiotic bacteria. 25+ years of GR-1/RC-14 Research/Clinical studies 1988 First research on GR-1/RC-14 strains begin 27 Clinical studies published between 2001 and 2014 2006 Fem-Dophilus introduced (2006)

Copyright 2021 Jarrow Formulas

Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

Note: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.

Note: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.

Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.

Updates based on official taxonomy reclassification.

Keep out of the reach of children.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others. RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S. Strains Matter Jarrow Formulas probiotics contain clinically documented strains

Vaginal/urinary tract health

25+ years of research/clinical studies

Patented strains L. Rhamnosus GR-1 & L. Reuteri RC-14

Oral Probiotic Supplement

Keep refrigerated.

Free of major allergens. No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.

Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.

Gluten free

V Vegan Veggie Cap

Ipro

Made in Denmark by Chr. Hansen A/S